Currently a research laboratory specialist in the Department of Radiology at Michigan Medicine. My primary interest is drug development, with a focus in PET radiopharmaceutical agents. I've spent several years developing agents for imaging cholesterol dysregulation associated with neuroendocrine tumors, atherosclerosis, and other diseases. Additionally, I am involved in the development of novel radiochemical methodology.